In murine models, knockout of the core 3 O-glycan–synthesizing enzyme B3GNT6 leads to a marked reduction in Muc2 mucin in the colonic mucosa, increased intestinal permeability, and greater susceptibility to colitis and colorectal tumorigenesis following pathogenic challenge or chemical injury [36,42]. The gene discussed is MUC2; the disease is colitis.